Annovis Bio Financial Overview
Annovis Bio's market cap is currently $96.74M. The company's EPS TTM is $-0.37; its P/E ratio is -2.65; Annovis Bio is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
